Mavacamten for hypertrophic obstructive cardiomyopathy reply

Jacoby Daniel; Ho Carolyn Y.; Lester Steven J.; Wang Andrew; Olivotto Iacopo

首页> 外文期刊>The Lancet >Mavacamten for hypertrophic obstructive cardiomyopathy reply

【24h】

Mavacamten for hypertrophic obstructive cardiomyopathy reply

机译：Mavacamten用于肥厚性阻塞性心肌病回复

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Lancet 》 |2021年第10272期| 共2页
作者
Jacoby Daniel; Ho Carolyn Y.; Lester Steven J.; Wang Andrew; Olivotto Iacopo;
展开▼
作者单位

Yale Univ Dept Internal Med Sec Cardiovasc Med New Haven CT USA;

Brigham &

Womens Hosp Div Cardiovasc Med 75 Francis St Boston MA 02115 USA;

Mayo Clin Arizona Dept Cardiovasc Dis Phoenix AZ USA;

Duke Univ Sch Med Durham NC USA;

Azienda Osped Univ Careggi Cardiomyopathy Unit I-50134 Florence Italy;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生 ;
关键词

相似文献

外文文献
中文文献
专利

1. Uric acid is associated with cardiac death in patients with hypertrophic obstructive cardiomyopathy [J] . Jun GAO, Chun-Li SHAO, Xiang-Bin MENG, 老年心脏病学杂志（英文版） . 2021 ,第004期
2. Hemorrhagic stroke caused by moyamoya disease in a patient with obstructive hypertrophic cardiomyopathy [J] . Sheng Liu, Yu Kang, Qing Zhang, 中华医学杂志（英文版） . 2021 ,第003期
3. Correlations between low thyroid function and incidence of atrial fibrillation in hypertrophic obstructive cardiomyopathy [J] . Liu Li-Min, Shen Li-Shui, Liu Shang-Yu, 慢性疾病与转化医学：英文版 . 2020 ,第001期
4. Correlations between low thyroid function and incidence of atrial fibrillation in hypertrophic obstructive cardiomyopathy [J] . Li-Min Liu, Li-Hui Zheng, Li-Gang Ding, 慢性疾病与转化医学（英文） . 2020 ,第001期
5. Mavacamten for hypertrophic obstructive cardiomyopathy [J] . Quintana Eduard, Bajona Pietro, Myers Patrick O. The Lancet . 2021 ,第10272期

机译：Mavacamten用于肥厚性阻塞性心肌病
6. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial [J] . Spertus John A., Fine Jennifer T., Elliott Perry, The Lancet . 2021 ,第10293期

机译：Mavacamten用于治疗症状性抑菌性肥厚性心肌病（探险家 - HCM）：随机，双盲，安慰剂控制，第3期审判的健康状况分析
7. Mavacamten Favorably Impacts Cardiac Structure in Obstructive Hypertrophic Cardiomyopathy EXPLORER-HCM Cardiac Magnetic Resonance Substudy Analysis [J] . Saberi Sara, Cardim Nuno, Yamani Mohamad, Circulation: An Official Journal of the American Heart Association . 2021 ,第6期

机译：Mavacamten有利地影响阻塞性肥厚性心肌病的心脏结构 - HCM心脏磁共振血浆归档分析
8. Attenuation of 3-Dimensional Epicardial Strain from Cardiac Magnetic Resonance Associated with Obstructive Hypertrophic Cardiomyopathy [C] . X.D. Zhao, R.S. Tan, H.C. Tang International Economic Conference for Innovation in Biomedical Engineering and life Sciences . 2016

机译：与阻塞性肥厚性心肌病相关的心脏磁共振的三维外膜菌株的衰减
9. An Atlas-Based Approach to Improve Differentiation between Adolescent Athletes and Adolescent Hypertrophic Cardiomyopathy Patients [D] . Sihra, Sandhya Cecilia Kaur. 2021

机译：基于地图集的方法来改善青少年运动员和青少年肥厚性心肌病变患者的分化
10. Reply to ‘Machine learning detection of obstructive hypertrophic cardiomyopathy using a wearable biosensor’ [O] . Reinier van Mourik, Onur Dur, Stephen B. Heitner, 2019

机译：回复使用可穿戴式生物传感器对梗阻性肥厚型心肌病进行机器学习检测
11. Mavacamten for hypertrophic obstructive cardiomyopathy [O] . Eduard Quintana, Pietro Bajona, Patrick O Myers 2021

机译：Mavacamten用于肥厚性阻塞性心肌病
12. Dynamic Analysis of the Correlation Integral of Heart Rate Variability in Hypertrophic Cardiomyopathy Patients. [R] . Carvajal, R., Vallverdu, M., Zebrowski, J. J., 2001

机译：肥厚型心肌病患者心率变异相关积分的动态分析。

Mavacamten for hypertrophic obstructive cardiomyopathy reply

著录项

相似文献

相关主题

期刊订阅